Jonathan Visentin

2.4k total citations
231 papers, 1.7k citations indexed

About

Jonathan Visentin is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Transplantation. According to data from OpenAlex, Jonathan Visentin has authored 231 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 206 papers in Immunology, 54 papers in Radiology, Nuclear Medicine and Imaging and 32 papers in Transplantation. Recurrent topics in Jonathan Visentin's work include T-cell and B-cell Immunology (188 papers), Immune Cell Function and Interaction (180 papers) and Immunotherapy and Immune Responses (84 papers). Jonathan Visentin is often cited by papers focused on T-cell and B-cell Immunology (188 papers), Immune Cell Function and Interaction (180 papers) and Immunotherapy and Immune Responses (84 papers). Jonathan Visentin collaborates with scholars based in France, Italy and United Kingdom. Jonathan Visentin's co-authors include Gwendaline Guidicelli, Jean‐Luc Taupin, Marine Cargou, Lionel Couzi, Pierre Merville, Vincent Elsermans, Isabelle Top, Mamy Ralazamahaleo, Marco Andreani and Thomas Bachelet and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Scientific Reports.

In The Last Decade

Jonathan Visentin

211 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan Visentin France 20 990 864 467 324 203 231 1.7k
Gwendaline Guidicelli France 19 699 0.7× 701 0.8× 389 0.8× 202 0.6× 194 1.0× 112 1.3k
Falko M. Heinemann Germany 18 369 0.4× 330 0.4× 260 0.6× 307 0.9× 85 0.4× 64 1.1k
Marcelo J. Pando United States 20 1.6k 1.6× 221 0.3× 237 0.5× 511 1.6× 63 0.3× 31 2.1k
Konstantin Doberer Austria 16 168 0.2× 377 0.4× 223 0.5× 159 0.5× 48 0.2× 37 789
Gerhard Opelz Germany 16 266 0.3× 272 0.3× 180 0.4× 73 0.2× 65 0.3× 39 652
Thuong Hien Tran Germany 16 285 0.3× 425 0.5× 248 0.5× 141 0.4× 66 0.3× 45 743
J. Gibson Lanier United States 8 984 1.0× 347 0.4× 213 0.5× 264 0.8× 131 0.6× 8 1.3k
Marie‐Christine Moal France 11 211 0.2× 678 0.8× 393 0.8× 329 1.0× 40 0.2× 25 1.0k
Stéphanie Louis France 11 530 0.5× 454 0.5× 263 0.6× 195 0.6× 63 0.3× 15 947
Marc Lúcia Spain 15 275 0.3× 424 0.5× 214 0.5× 332 1.0× 46 0.2× 19 760

Countries citing papers authored by Jonathan Visentin

Since Specialization
Citations

This map shows the geographic impact of Jonathan Visentin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Visentin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Visentin more than expected).

Fields of papers citing papers by Jonathan Visentin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Visentin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Visentin. The network helps show where Jonathan Visentin may publish in the future.

Co-authorship network of co-authors of Jonathan Visentin

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Visentin. A scholar is included among the top collaborators of Jonathan Visentin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Visentin. Jonathan Visentin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cargou, Marine, et al.. (2025). Characterisation of the HLA‐DPB1*104:01:08 Allele by Sequencing‐Based Typing. HLA. 105(5). e70245–e70245.
2.
Cargou, Marine, et al.. (2025). Characterisation of the Novel HLA ‐C*07:1173 Allele by Sequencing‐Based Typing. HLA. 105(4). e70186–e70186.
3.
Cargou, Marine, et al.. (2025). Characterisation of the Novel HLA‐DQA1*01:170 by Sequencing‐Based Typing. HLA. 105(4). e70185–e70185.
4.
Elsermans, Vincent, et al.. (2025). Characterisation of the Novel HLA‐DQB1*05:357 Allele by Sequencing‐Based Typing. HLA. 105(5). e70269–e70269.
5.
Cargou, Marine, et al.. (2025). Characterisation of the Novel HLA‐A*01:470 Allele by Sequencing‐Based Typing. HLA. 105(4). e70202–e70202.
6.
Cargou, Marine, et al.. (2025). Characterisation of the Novel HLA‐DQA1*01:169 Allele by Sequencing‐Based Typing. HLA. 105(4). e70184–e70184.
7.
Cargou, Marine, et al.. (2025). Characterisation of the Novel HLADRB1 * 14 : 268 Allele by Sequencing‐Based Typing. HLA. 105(4). e70181–e70181.
9.
Cargou, Marine, Marco Andreani, Tiziana Galluccio, Mamy Ralazamahaleo, & Jonathan Visentin. (2024). Characterisation of the novel HLA‐DQA1*01:02:24 allele by sequencing‐based typing. HLA. 104(3). e15671–e15671. 2 indexed citations
10.
Visentin, Jonathan, et al.. (2024). Characterization of the novel HLA‐DRB3*02:194 allele by sequencing‐based typing. HLA. 103(1). e15353–e15353. 2 indexed citations
11.
Cargou, Marine, Vincent Elsermans, Isabelle Top, Gwendaline Guidicelli, & Jonathan Visentin. (2024). Characterisation of the novel HLA‐B*51:411 allele by sequencing‐based typing. HLA. 104(3). e15679–e15679. 2 indexed citations
12.
Cargou, Marine, Vincent Elsermans, Isabelle Top, Gwendaline Guidicelli, & Jonathan Visentin. (2024). Characterisation of the novel HLA‐A*26:247 allele by sequencing‐based typing. HLA. 104(3). e15673–e15673. 2 indexed citations
13.
Cargou, Marine, et al.. (2024). Characterisation of the novel HLA‐DRB4*01:01:12 allele by sequencing‐based typing. HLA. 103(5). e15538–e15538. 1 indexed citations
14.
Elsermans, Vincent, et al.. (2024). Characterization of the Novel HLA‐C*07:01:126 Allele by Sequencing‐Based Typing. HLA. 104(4). e15713–e15713. 1 indexed citations
15.
Visentin, Jonathan, et al.. (2024). Characterisation of the novel HLA‐DQA1*05:112 allele by sequencing‐based typing. HLA. 104(1). e15621–e15621. 2 indexed citations
16.
Cargou, Marine, et al.. (2023). Characterization of the novel HLA‐A*24:587 allele by sequencing‐based typing. HLA. 102(2). 216–218. 2 indexed citations
17.
Cargou, Marine, et al.. (2023). Characterization of the novel HLA‐C*05:01:01:81Q allele by sequencing‐based typing. HLA. 102(1). 93–95. 1 indexed citations
18.
Cargou, Marine, et al.. (2023). Characterization of the novel HLA‐DPA1*01:150 allele by sequencing‐based typing. HLA. 102(4). 543–545. 2 indexed citations
19.
Elsermans, Vincent, et al.. (2023). Characterization of the novel HLA‐C*03:552 allele by sequencing‐based typing. HLA. 102(2). 237–238. 2 indexed citations
20.
Visentin, Jonathan, Hannah Kaminski, Arnaud Del Bello, et al.. (2020). Comparison of two strategies based on mammalian target of rapamycin inhibitors in secondary prevention of non‐melanoma skin cancer after kidney transplantation, a pilot study. Clinical Transplantation. 35(3). e14207–e14207. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026